What is the Peptron Inc. stock price forecast?

Peptron Inc. is currently trading at ₩231,000. View real-time AI analysis on Alpha Lenz.

What is Peptron Inc. insider trading activity?

View the latest insider trading data for Peptron Inc. on Alpha Lenz.

What is Peptron Inc.'s P/E ratio?

Peptron Inc.'s P/E ratio is -388.0.

Peptron Inc.

KRX · 087010

₩231,000+1,000(+0.43%)Market closed

Ask about Peptron Inc.'s future dividend policy...

Alpha Chat Insight

“Peptron Inc. trades at a P/E of -388.0 (undervalued) with modest ROE of -9.4%.”

Ask for details →

Company Overview

Peptron Inc. is a biotechnology company specializing in the development and manufacturing of pharmaceutical products with a focus on peptide-based therapies. Its primary function is to innovate in long-acting peptide formulations, enhancing the delivery and efficacy of therapeutic solutions for various medical conditions. The company's products are utilized across a spectrum of medical sectors, including endocrinology, oncology, and neurology, offering potentially transformative treatments for chronic diseases. Peptron Inc. also engages in collaborative research and development efforts, frequently partnering with academic institutions and other biotech firms to advance the scope and impact of its technologies. In the financial market, Peptron Inc. is recognized for its contributions to the biopharmaceutical sector, reflecting its commitment to pioneering treatment solutions and its potential in influencing future healthcare advancements.

CEO최호일

Websitehttps://www.peptron.co.kr

SectorCommon Stock

IndustryCommon Stock

Company Statistics

FY 2025

Profile

₩5,386,307,850,000Market Cap

₩5,634,817,670Revenue

23.32MShares Out

0Employees

Margins

27.18%Gross

-251.32%EBITDA

-377.25%Operating

-254.25%Pre-Tax

-245.33%Net

Valuation

-387.95P/E

37.77P/B

951.76EV/Sales

-380.48EV/EBITDA

-227.41P/FCF

Growth (CAGR)

-1.04%Rev 3Yr

12.54%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-7.95%ROA

-9.41%ROE

-7.48%ROIC

Financial Health

₩4,377,757,820Cash & Cash Equivalents

₩32,593,184,270Net Debt

26.03%Debt/Equity

N/AInterest Cov